United Therapeutics, Former NFL Player Devon Still Partner to Launch “Braving NeuroBLASToma” Initiative
Downtown Silver Spring-based United Therapeutics today announced it has partnered with former NFL player Devon Still and his daughter Leah, a survivor of high-risk neuroblastoma, to launch the educational initiative Braving NeuroBLASToma. The initiative, launched during National Childhood Cancer Awareness Month, aims to shine a light on neuroblastoma, a rare childhood cancer affecting immature nerve cells called neuroblasts. Neuroblastoma often develops in infants and children under the age of five, but the average age of diagnosis is between one and two years old.